These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 29251204

  • 21. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E.
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [Abstract] [Full Text] [Related]

  • 22. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
    Yu C, Tang W, Ren T, Chen Q, Lu R, Gao Y.
    J Endovasc Ther; 2024 Jun; 31(3):390-399. PubMed ID: 36189843
    [Abstract] [Full Text] [Related]

  • 23. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G, Schroeder H, Albrecht T, Reimer P, Diehm N, Baeriswyl JL, Brechtel K, Speck U, Zeller T.
    J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
    [Abstract] [Full Text] [Related]

  • 24. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E, Gerardi D, Magliulo F, Zhelev D, Chervenkoff V, Taeymans K, Kotasov D, Goverde P, Giugliano G, Trimarco B, Esposito G.
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [Abstract] [Full Text] [Related]

  • 25. Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease.
    Kuo TT, Chen PL, Huang CY, Lee CY, Shih CC, Chen IM.
    J Vasc Surg; 2019 Jan; 69(1):141-147. PubMed ID: 30104098
    [Abstract] [Full Text] [Related]

  • 26. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG, Hossain P, Jawaid O, Alvandi B, Foley TR, Singh GD, Waldo SW, Laird JR, Armstrong EJ.
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [Abstract] [Full Text] [Related]

  • 27. Rotational atherectomy with adjunctive balloon angioplasty in calcified chronic total occlusions of superficial femoral artery.
    Engin AY, Saydam O.
    Vascular; 2021 Oct; 29(5):682-692. PubMed ID: 33167805
    [Abstract] [Full Text] [Related]

  • 28. Short-term Results of the RAPID Randomized Trial of the Legflow Paclitaxel-Eluting Balloon With Supera Stenting vs Supera Stenting Alone for the Treatment of Intermediate and Long Superficial Femoral Artery Lesions.
    de Boer SW, van den Heuvel DAF, de Vries-Werson DAB, Vos JA, Fioole B, Vroegindeweij D, Elgersma OE, Tutein Nolthenius RP, Heyligers JMM, Bosma GPT, de Leeuw B, Bouwman LH, Böckler D, Dovzhanskiy DI, Vos FWF, Vink TWF, Hooijboer PGA, Hissink RJ, de Vries JPM.
    J Endovasc Ther; 2017 Dec; 24(6):783-792. PubMed ID: 28795638
    [Abstract] [Full Text] [Related]

  • 29. Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial.
    Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H, MDT-2113 SFA Japan Investigators.
    Catheter Cardiovasc Interv; 2019 Mar 01; 93(4):664-672. PubMed ID: 30747489
    [Abstract] [Full Text] [Related]

  • 30. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D, RANGER SFA Investigators.
    JACC Cardiovasc Interv; 2018 May 28; 11(10):934-941. PubMed ID: 29730375
    [Abstract] [Full Text] [Related]

  • 31. Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Rocha-Singh KJ, Sachar R, DeRubertis BG, Nolte-Ernsting CCA, Winscott JG, Krishnan P, Scott EC, Garcia LA, Baeriswyl JL, Ansel G, Rosenfield K, Zeller T, REALITY Investigators.
    Catheter Cardiovasc Interv; 2021 Sep 28; 98(3):549-558. PubMed ID: 34080792
    [Abstract] [Full Text] [Related]

  • 32. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I.
    Xu Y, Jia X, Zhang J, Zhuang B, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W.
    JACC Cardiovasc Interv; 2018 Dec 10; 11(23):2347-2353. PubMed ID: 30448170
    [Abstract] [Full Text] [Related]

  • 33. Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty.
    Lin TC, Huang CY, Chen PL, Lee CY, Shih CC, Chen IM.
    J Endovasc Ther; 2018 Jun 10; 25(3):313-319. PubMed ID: 29673299
    [Abstract] [Full Text] [Related]

  • 34. Vessel Preparation in Infrapopliteal Arterial Disease: A Systematic Review and Meta-Analysis.
    Nugteren MJ, Welling RHA, Bakker OJ, Ünlü Ç, Hazenberg CEVB.
    J Endovasc Ther; 2024 Apr 10; 31(2):191-202. PubMed ID: 36062761
    [Abstract] [Full Text] [Related]

  • 35. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Giacoppo D, Cassese S, Harada Y, Colleran R, Michel J, Fusaro M, Kastrati A, Byrne RA.
    JACC Cardiovasc Interv; 2016 Aug 22; 9(16):1731-42. PubMed ID: 27539695
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Orbital Atherectomy Prior to Drug-Coated Balloon Angioplasty in Calcified Infrapopliteal Lesions: A Randomized, Multicenter Pilot Study.
    Zeller T, Giannopoulos S, Brodmann M, Werner M, Andrassy M, Schmidt A, Blessing E, Tepe G, Armstrong EJ.
    J Endovasc Ther; 2022 Dec 22; 29(6):874-884. PubMed ID: 35086385
    [Abstract] [Full Text] [Related]

  • 38. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E.
    J Vasc Surg; 2019 Sep 22; 70(3):981-995.e10. PubMed ID: 31126769
    [Abstract] [Full Text] [Related]

  • 39. Outcomes of Adjunctive Drug-Coated Versus Uncoated Balloon after Atherectomy in Femoropopliteal Artery Disease.
    Lee YJ, Ko YG, Ahn CM, Hong SJ, Kim JS, Kim BK, Choi D, Hong MK, Jang Y.
    Ann Vasc Surg; 2020 Oct 22; 68():391-399. PubMed ID: 32339691
    [Abstract] [Full Text] [Related]

  • 40. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.
    Chen Z, Guo W, Jiang W, Wang F, Fu W, Zou Y, Deckers S, Li P, Popma JJ, Jaff MR.
    J Endovasc Ther; 2019 Aug 22; 26(4):471-478. PubMed ID: 31204595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.